Becton Dickinson will spin off its biosciences and diagnostic business and merge it with Waters, and plans to use at least $2 billion of the proceeds to buy back stock.
www.marketwatch.com
#Becton #Dickinson #spinoff #deal #stock #falling
Related Posts

HSBC Sees Pharma Poised to Outperform in 2026, Lifts GSK Target
GSK plc (NYSE:GSK) is included among the 15 Global Dividend Stocks to Diversify Your Portfolio. HSBC Sees Pharma Poised to…
Tech stocks have been shaky, but these 20 companies could still see rocketing sales growth
Sandisk and Micron could see industry-leading revenue growth in the coming years. www.marketwatch.com #Tech #stocks #shaky #companies #rocketing #sales #growth…

As the Fed pauses, so do home equity rates
The national average rates for second mortgage products, such as home equity loans and lines of credit, continue to hold…

